Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed May 15, 2012 · 10-Q · 45 days after period end · 0001062993-12-001798
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Net Income | -$910.20K | -$1.97M |
| EPS Diluted | -$0.03 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 15, 2012 · 45 d after period end
